| To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting. (NCT05576051) | Pfizer | 2015-06-04 |
| Pregnancy and Medically Assisted Conception in Rare Diseases (NCT02450396) | Assistance Publique - Hôpitaux de Paris | 2015-06-01 |
| Relationship of YWHAH Polymorphisms to Rheumatoid Arthritis Disease Severity (NCT03190746) | Keesler Air Force Base Medical Center | 2015-06-01 |
| Tritanium® Study in Japan (NCT02552069) | Stryker Japan K.K. | 2015-06-01 |
| Real-life Experience of Tofacitinib in Patients With Treatment-Resistant Rheumatoid Arthritis (NCT04674085) | Umraniye Education and Research Hospital | 2015-06-01 |
| Scorpio Non Restricted Geometry (NRG) Study in Japan (NCT02552082) | Stryker Japan K.K. | 2015-06-01 |
| Non-Interventional Study of Tocilizumab Subcutaneous (SC) Monotherapy in Participants With Rheumatoid Arthritis (RA) (NCT02402686) | Hoffmann-La Roche | 2015-05-20 |
| Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy Patients (NCT02456844) | Bristol-Myers Squibb | 2015-05-01 |
| Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases (NCT03454932) | Bone Therapeutics S.A | 2015-05-01 |
| An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective (NCT02566967) | Norman B. Gaylis, MD | 2015-05-01 |
| Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis (NCT02404558) | Sanofi | 2015-05-01 |
| G7 Acetabular System vs. Exceed ABT Acetabular System in THA (NCT02340390) | Zimmer Biomet | 2015-05-01 |
| A Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation in Healthy Subjects (NCT02460393) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2015-05-01 |
| Project JAY THA Registration Study (NCT02347384) | Smith & Nephew Orthopaedics (Beijing) Limited | 2015-04-20 |
| Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate (NCT02393378) | Takeda | 2015-04-08 |
| ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate (NCT02387762) | Acerta Pharma BV | 2015-04-01 |
| First-in-Human Single Ascending Dose of SHR0302 (NCT02423538) | Jiangsu HengRui Medicine Co., Ltd. | 2015-04-01 |
| Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study (NCT02433340) | AbbVie | 2015-04-01 |
| Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis (NCT02430909) | UCB Celltech | 2015-04-01 |
| Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis (NCT02499315) | Amgen | 2015-04-01 |
| Safety, Tolerability, PK, PD, and Immunogenicity of Single and Multiple Ascending Intravenous Doses of FR104 (NCT02800811) | OSE Immunotherapeutics | 2015-04-01 |
| A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis. (NCT02486302) | Pfizer | 2015-03-24 |
| Relationship Between T LYmphocytes Depletion and Clinical Response to RITUXimab in Rheumatoid Arthritis (LYRITUX) (NCT02304354) | University Hospital, Tours | 2015-03-09 |
| Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα (NCT02620189) | Queen Mary University of London | 2015-03-01 |
| Optimizing the Management of Flares in Patients With Rheumatoid Arthritis (RA) (NCT02382783) | Mayo Clinic | 2015-03-01 |
| Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to Golimumab (NCT02414984) | Janssen-Cilag, S.A. | 2015-03-01 |
| Reduced Ultrasound Counts in Rheumatoid Arthritis (NCT02389283) | Hospital General Universitario Gregorio Marañon | 2015-03-01 |
| PBR28 PET and Inflammatory Arthritis (NCT02361385) | University of Oxford | 2015-03-01 |
| A Trial to Determine the Effects of Exercise in Inflammatory Bowel Disease and Rheumatoid Arthritis (NCT02463916) | University College Cork | 2015-03-01 |
| Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis (NCT02638259) | Sandoz | 2015-02-21 |
| Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission (NCT02373813) | Amgen | 2015-02-20 |
| Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity (NCT02466581) | Karolinska Institutet | 2015-02-03 |
| Improved Ability to Cope With Everyday Life Through a Person-centered Training Program in Elderly Patients With Rheumatoid Arthritis - PEP-walk Study (NCT02397798) | Vastra Gotaland Region | 2015-02-01 |
| Outpatient Follow-up on Demand in Rheumatoid Arthritis (NCT04476875) | University Hospital, Gentofte, Copenhagen | 2015-02-01 |
| A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA) (NCT02373202) | Sanofi | 2015-02-01 |
| PS150 Total Knee Arthroplasty Outcomes Registry (NCT02319291) | DePuy Orthopaedics | 2015-02-01 |
| Incorporation of Patient Reported Outcomes Data in the Care of US Veterans With Rheumatoid Arthritis (NCT02326532) | North Florida Foundation for Research and Education | 2015-02-01 |
| Observational Study of Golimumab Intravenous Infusion (NCT02390700) | Janssen Inc. | 2015-02-01 |
| Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH) (NCT02332590) | Sanofi | 2015-01-28 |
| Progress at Work - The Impact of Adalimumab on Work Related Productivity in Patients With Rheumatoid Arthritis (NCT02362074) | AbbVie | 2015-01-21 |
| A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects (NCT02198651) | AbbVie | 2015-01-05 |
| A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis (NCT02309359) | Ablynx, a Sanofi company | 2015-01-01 |
| Outcomes Data of Adipose Stem Cells to Treat Rheumatoid Arthritis (NCT02348086) | StemGenex | 2015-01-01 |
| Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line Biological Therapy of Patients With Active Rheumatoid Arthritis (NCT02744196) | Biocad | 2015-01-01 |
| A Study to Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving Methotrexate (NCT04192617) | SinoMab BioScience Ltd | 2014-12-31 |
| Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA) (NCT02379091) | Takeda | 2014-12-17 |
| 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS) (NCT02328027) | Advanced Accelerator Applications | 2014-12-11 |
| Consortium of Early Arthritis Cohorts USA (NCT02386527) | Hospital for Special Surgery, New York | 2014-12-01 |
| Relationship Between the Activity of Rheumatoid Arthritis and Lymph Node Morphology and Lymphatics Drainage (NCT02876874) | Shanghai University of Traditional Chinese Medicine | 2014-12-01 |
| Eccentric Exercise and Cachexia in Rheumatoid Arthritis (NCT02320188) | University Hospital, Clermont-Ferrand | 2014-12-01 |
| Comparison of Treatments Following Total Knee Replacement (NCT02237911) | University of Pittsburgh | 2014-12-01 |
| Home Monitoring of Patients With Rheumatoid Arthritis - an eHealth Development Study (NCT02317939) | Henrik Gudbergsen | 2014-12-01 |
| A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis (NCT02281552) | Pfizer | 2014-11-18 |
| Efficacy and Safety of Traditional Chinese Medicine (TCM) Comprehensive Therapy in Patients With Rheumatoid Arthritis (NCT02551575) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2014-11-01 |
| A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis (NCT02287610) | Amgen | 2014-11-01 |
| Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study (NCT04306939) | University of Pittsburgh | 2014-11-01 |
| Walk for Rheumatoid Arthritis (WARA Study) (NCT02467205) | University of Glasgow | 2014-11-01 |
| Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis (NCT02296775) | Dr. Reddy's Laboratories Limited | 2014-11-01 |
| Signature Acetabular Posterior/Lateral Data Collection (NCT02220478) | Zimmer Biomet | 2014-11-01 |
| Mobile Medically Supervised Patient Management in Rheumatoid Arthritis (NCT02565225) | Heinrich-Heine University, Duesseldorf | 2014-11-01 |
| A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI) (NCT02293902) | Sanofi | 2014-11-01 |
| An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044 (NCT02319642) | UCB Pharma SA | 2014-11-01 |
| ACTH Gel Therapy in Rheumatoid Arthritis (NCT02030028) | Dana Ascherman | 2014-11-01 |
| Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries (NCT02281747) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2014-10-24 |
| Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA) (NCT02221258) | Kang Stem Biotech Co., Ltd. | 2014-10-01 |
| Safety Profile of Nulojix in Home Infusion Settings (NCT02500498) | Bristol-Myers Squibb | 2014-10-01 |
| Is Ultrasound Remission a Real Remission? Does Ultrasound Permit to Achieve and Maintain the Remission in Rheumatoid Arthritis Patients More Efficiently Than Clinical Scores? (NCT02140229) | Assistance Publique - Hôpitaux de Paris | 2014-10-01 |
| Patient Perceived Outcome After Total Wrist Arthroplasty With a New Total Wrist Arthroplasty Implant (NCT02336009) | Örebro University, Sweden | 2014-10-01 |
| A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA) (NCT02265705) | Eli Lilly and Company | 2014-10-01 |
| The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Cartilage in (RA) Patients (NCT02150473) | Heinrich-Heine University, Duesseldorf | 2014-10-01 |
| Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB) (NCT02102594) | Charite University, Berlin, Germany | 2014-10-01 |
| The NOR-SWITCH Study (NCT02148640) | Diakonhjemmet Hospital | 2014-10-01 |
| Red Yeast Rice and Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis (NCT02257047) | Chengdu PLA General Hospital | 2014-10-01 |
| A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTX (NCT02270632) | Philogen S.p.A. | 2014-10-01 |
| Cognitive-behavioral Treatment for Rheumatoid Arthritis (NCT02257073) | Chengdu PLA General Hospital | 2014-10-01 |
| Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis (NCT02885818) | University Hospital, Brest | 2014-10-01 |
| Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System (NCT02175576) | Zimmer Biomet | 2014-10-01 |
| TC-A Registration Study (NCT02139345) | Smith & Nephew Medical (Shanghai) Ltd | 2014-09-23 |
| Early Rheumatoid Arthritis COR Intervention (NCT02246257) | MD, PhD, Annemarie Lyng Svensson | 2014-09-01 |
| Digitized Grip Strength (NCT02197507) | University Hospital, Montpellier | 2014-09-01 |
| Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab (NCT01717859) | University of California, Los Angeles | 2014-09-01 |
| A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate (NCT02097264) | Novo Nordisk A/S | 2014-09-01 |
| A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers (NCT02154425) | UCB BIOSCIENCES, Inc. | 2014-09-01 |
| A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). (NCT02222493) | Pfizer | 2014-08-26 |
| Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice (NCT02202837) | Pfizer | 2014-08-12 |
| A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDs (NCT02308163) | Astellas Pharma Inc | 2014-08-08 |
| Real World Effectiveness of Abatacept in Rheumatoid Arthritis Patients: a Prospective, Single-arm, Open-label, Multi-center Observational Study in Taiwan (NCT02335606) | Bristol-Myers Squibb | 2014-08-06 |
| Duration of Immune Response to Influenza Vaccination in Patients With RA (NCT02311855) | Bassett Healthcare | 2014-08-01 |
| A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986104 in Healthy Male Subjects (NCT02211469) | Bristol-Myers Squibb | 2014-08-01 |
| The Effect of Square Dance on Rheumatoid Arthritis (NCT02258269) | Chengdu PLA General Hospital | 2014-08-01 |
| PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis (NCT02149121) | Celltrion | 2014-08-01 |
| Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis (NCT02176876) | Gilead Sciences | 2014-08-01 |
| Biomarkers of Remission in Rheumatoid Arthritis (BioRRA) (NCT02219347) | Newcastle-upon-Tyne Hospitals NHS Trust | 2014-08-01 |
| Qingkailing Injection Versus Puerarin Injection on Withdrawal Rate of Corticosteroids in Patients With Active Rheumatoid Arthritis (NCT02264301) | Chengdu PLA General Hospital | 2014-08-01 |
| Puerarin Versus Atorvastatin in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases (NCT02219191) | Chengdu PLA General Hospital | 2014-08-01 |
| Local, Non-Interventional Study of RoActemra (Tocilizumab) in Poland (ACT-POL): First-Line Treatment in Routine Clinical Practice of Participants With Rheumatoid Arthritis (RA) (NCT02234960) | Hoffmann-La Roche | 2014-08-01 |
| A Study to Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) Treatment (NCT02305849) | Astellas Pharma Inc | 2014-07-25 |
| Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab) (NCT02101307) | Hoffmann-La Roche | 2014-07-09 |
| A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate (NCT02141997) | AbbVie | 2014-07-01 |
| A Study of Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid Arthritis (NCT02151851) | UCB Pharma SA, Belgium | 2014-07-01 |